{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:14:57Z","timestamp":1787620497893,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.vaccine.2021.07.043","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T07:55:13Z","timestamp":1631692513000},"page":"6691-6699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Protective immunity induced by concurrent intradermal injection of porcine circovirus type 2 and Mycoplasma hyopneumoniae inactivated vaccines in pigs"],"prefix":"10.1016","volume":"39","author":[{"given":"Sim-In","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Gi","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"ul Salam Mattoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2837-3365","authenticated-orcid":false,"given":"Salik","family":"Nazki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Prasad Aganja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1152-2248","authenticated-orcid":false,"given":"Seung-Chai","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8384-1854","authenticated-orcid":false,"given":"Amina","family":"Khatun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonsu","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyun","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Myeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2021.07.043_b0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1090-0233(03)00182-5","article-title":"Postweaning multisystemic wasting syndrome: a review of aetiology, diagnosis and pathology","volume":"168","author":"CHAE","year":"2004","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2021.07.043_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/v9050099","article-title":"Porcine circovirus type 2 (PCV2) vaccines in the context of current molecular epidemiology","volume":"9","author":"Karuppannan","year":"2017","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.043_b0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51473-6","article-title":"Environmental distribution of Porcine Circovirus Type 2 (PCV2) in swine herds with natural infection","volume":"9","author":"L\u00f3pez-Lorenzo","year":"2019","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2021.07.043_b0020","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1128\/CVI.05183-11","article-title":"Vaccination of dams increases antibody titer and improves growth parameters in finisher pigs subclinically infected with porcine circovirus type 2","volume":"18","author":"Kurmann","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.043_b0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.prevetmed.2013.02.010","article-title":"Cost of post-weaning multi-systemic wasting syndrome and porcine circovirus type-2 subclinical infection in England - an economic disease model","volume":"110","author":"Alarcon","year":"2013","journal-title":"Prev Vet Med"},{"issue":"1-2","key":"10.1016\/j.vaccine.2021.07.043_b0030","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.virusres.2011.12.002","article-title":"Epidemiology and transmission of porcine circovirus type 2 (PCV2)","volume":"164","author":"Rose","year":"2012","journal-title":"Virus Res"},{"issue":"1-2","key":"10.1016\/j.vaccine.2021.07.043_b0035","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.virusres.2011.10.005","article-title":"Porcine circovirus type 2 and its associated diseases in China","volume":"164","author":"Ge","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2021.07.043_b0040","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-020-00807-8","article-title":"Coinfections and their molecular consequences in the porcine respiratory tract","volume":"51","author":"Saade","year":"2020","journal-title":"Vet Res"},{"issue":"2-3","key":"10.1016\/j.vaccine.2021.07.043_b0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jcpa.2010.01.012","article-title":"An investigation of the pathology and pathogens associated with porcine respiratory disease complex in Denmark","volume":"143","author":"Hansen","year":"2010","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2021.07.043_b0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.vaccine.2016.11.085","article-title":"A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naive pigs under experimental conditions","volume":"35","author":"Opriessnig","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.07.043_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tvjl.2015.10.030","article-title":"Porcine respiratory disease complex: Interaction of vaccination and porcine circovirus type 2, porcine reproductive and respiratory syndrome virus, and Mycoplasma hyopneumoniae","volume":"212","author":"Chae","year":"2016","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2021.07.043_b0060","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12917-017-1195-0","article-title":"Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains","volume":"13","author":"Michiels","year":"2017","journal-title":"BMC Vet Res"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2021.07.043_b0065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/tbed.12677","article-title":"Update on Mycoplasma hyopneumoniae infections in pigs: knowledge gaps for improved disease control","volume":"65","author":"Maes","year":"2018","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2021.07.043_b0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.vetmic.2016.10.002","article-title":"Ten years of PCV2 vaccines and vaccination: Is eradication a possibility?","volume":"206","author":"Afghah","year":"2017","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.043_b0075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1743-422X-11-88","article-title":"Porcine circovirus type 2 in China: an update on and insights to its prevalence and control","volume":"11","author":"Zhai","year":"2014","journal-title":"Virol J"},{"issue":"13","key":"10.1016\/j.vaccine.2021.07.043_b0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/vr.104466","article-title":"Field study on the safety and efficacy of intradermal versus intramuscular vaccination against Mycoplasma hyopneumoniae","volume":"181","author":"Beffort","year":"2017","journal-title":"Vet Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.043_b0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1745-6673-4-25","article-title":"Exposure rate of needlestick and sharps injuries among Australian veterinarians","volume":"4","author":"Leggat","year":"2009","journal-title":"J Occup Med Toxicol"},{"key":"10.1016\/j.vaccine.2021.07.043_b0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.54846\/jshap\/718","article-title":"Evaluation of a needle-free injection device to prevent hematogenous transmission of porcine reproductive and respiratory syndrome virus","volume":"20","author":"Baker","year":"2012","journal-title":"J Swine Health Prod"},{"issue":"4","key":"10.1016\/j.vaccine.2021.07.043_b0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/j.2042-7670.2002.tb23931.x","article-title":"Transmission of porcine reproductive and respiratory syndrome virus by needles","volume":"150","author":"Otake","year":"2002","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2021.07.043_b0100","first-page":"113","article-title":"Targeting skin dendritic cells to improve intradermal vaccination","volume":"351","author":"Romani","year":"2012","journal-title":"Curr Top Microbiol"},{"key":"10.1016\/j.vaccine.2021.07.043_b0105","first-page":"25","article-title":"Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design","volume":"351","author":"Teunissen","year":"2012","journal-title":"Curr Top Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2021.07.043_b0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/vr.100239","article-title":"Clinical evaluation of intradermal vaccination against porcine enzootic pneumonia (Mycoplasma hyopneumoniae)","volume":"170","author":"Tassis","year":"2012","journal-title":"Vet Rec"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.043_b0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/vim.2000.13.143","article-title":"Characterization of immune response of young pigs to porcine circovirus type 2 infection","volume":"13","author":"Pogranichnyy","year":"2000","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2021.07.043_b0120","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2527\/jas.2012-5705","article-title":"Neutralizing antibodies against porcine circovirus type 2 in liquid pooled plasma contribute to the biosafety of commercially manufactured spray-dried porcine plasma","volume":"91","author":"Polo","year":"2013","journal-title":"J Anim Sci"},{"key":"10.1016\/j.vaccine.2021.07.043_b0125","first-page":"105","article-title":"Serological identification of mycoplasmas by growth and metabolic inhibition tests","volume":"104","author":"Poveda","year":"1998","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1016\/j.vaccine.2021.07.043_b0130","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/j.1365-2672.2009.04556.x","article-title":"Development of a quantitative Real-Time TaqMan PCR assay for determination of the minimal dose of Mycoplasma hyopneumoniae strain 116 required to induce pneumonia in SPF pigs","volume":"108","author":"Marois","year":"2010","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.vaccine.2021.07.043_b0135","first-page":"233","article-title":"Evaluation of commercial polyclonal- and monoclonal-antibody-based immunohistochemical tests for 2 genotypes of Porcine circovirus type 2 and comparison with in-situ hybridization assays","volume":"78","author":"Seo","year":"2014","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.vaccine.2021.07.043_b0140","first-page":"195","article-title":"Effect of Mycoplasma hyopneumoniae colonization at weaning on disease severity in growing pigs","volume":"71","author":"Fano","year":"2007","journal-title":"Canadian J Vet Res-Revue Canadienne De Recherche Veterinaire"},{"key":"10.1016\/j.vaccine.2021.07.043_b0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jim.2010.03.006","article-title":"Comparative in vitro stimulation with lipopolysaccharide to study TNFalpha gene expression in fresh whole blood, fresh and frozen peripheral blood mononuclear cells","volume":"357","author":"Chen","year":"2010","journal-title":"J Immunol Methods"},{"issue":"3","key":"10.1016\/j.vaccine.2021.07.043_b0150","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.immuni.2014.03.002","article-title":"Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli","volume":"40","author":"Duffy","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.043_b0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.virol.2012.04.009","article-title":"Porcine reproductive and respiratory syndrome virus induces CD4+CD8+CD25+Foxp3+ regulatory T cells (Tregs)","volume":"430","author":"Silva-Campa","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2021.07.043_b0160","first-page":"6351","article-title":"Quantification of Th1 and Th17 cells with intracellular staining following PMA\/ionomycin stimulation","volume":"71","author":"Karlsson","year":"2015","journal-title":"Curr Protoc Cytom"},{"key":"10.1016\/j.vaccine.2021.07.043_b0165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fimmu.2015.00020","article-title":"gammadelta T lymphocytes in the diagnosis of human T cell receptor immunodeficiencies","volume":"6","author":"Garcillan","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2021.07.043_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037513","article-title":"Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo","volume":"7","author":"Lili","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.043_b0175","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00436-018-6186-y","article-title":"Effect of regulatory T cells on the efficacy of the fatty acid-binding protein vaccine against Schistosoma japonicum","volume":"118","author":"Tang","year":"2019","journal-title":"Parasitol Res"},{"issue":"6","key":"10.1016\/j.vaccine.2021.07.043_b0180","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1080\/21645515.2018.1434384","article-title":"Regulatory T cells (Tregs): a major immune checkpoint to consider in combinatorial therapeutic HIV-1 vaccines","volume":"14","author":"Hubert","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"10.1016\/j.vaccine.2021.07.043_b0185","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/14760584.7.8.1201","article-title":"Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice","volume":"7","author":"Nicolas","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.07.043_b0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.trivac.2016.01.002","article-title":"Efficacy and safety of a new intradermal PCV2 vaccine in pigs","volume":"5","author":"Sno","year":"2016","journal-title":"Trials Vaccinol"},{"issue":"2-4","key":"10.1016\/j.vaccine.2021.07.043_b0195","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.vetmic.2013.11.025","article-title":"Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines","volume":"168","author":"Martelli","year":"2014","journal-title":"Vet Microbiol"},{"issue":"1-2","key":"10.1016\/j.vaccine.2021.07.043_b0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virusres.2011.09.014","article-title":"Concurrent infections are important for expression of porcine circovirus associated disease","volume":"164","author":"Opriessnig","year":"2012","journal-title":"Virus Res"},{"issue":"2-3","key":"10.1016\/j.vaccine.2021.07.043_b0205","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jcpa.2012.01.003","article-title":"Simultaneous porcine circovirus type 2 and Mycoplasma hyopneumoniae co-inoculation does not potentiate disease in conventional pigs","volume":"147","author":"Sibila","year":"2012","journal-title":"J Comp Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.043_b0210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tvjl.2012.06.031","article-title":"Commercial porcine circovirus type 2 vaccines: efficacy and clinical application","volume":"194","author":"Chae","year":"2012","journal-title":"Vet J"},{"issue":"3-4","key":"10.1016\/j.vaccine.2021.07.043_b0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.vetmic.2009.09.056","article-title":"Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination","volume":"142","author":"Opriessnig","year":"2010","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.043_b0220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jviromet.2003.12.007","article-title":"Comparison of porcine circovirus type 2 load in serum quantified by a real time PCR in postweaning multisystemic wasting syndrome and porcine dermatitis and nephropathy syndrome naturally affected pigs","volume":"117","author":"Olvera","year":"2004","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.043_b0225","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-019-2091-6","article-title":"Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge","volume":"15","author":"Oh","year":"2019","journal-title":"BMC Vet Res"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.043_b0230","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.rvsc.2006.11.013","article-title":"The levels of PCV2 specific antibodies and viremia in pigs","volume":"83","author":"Carasova","year":"2007","journal-title":"Res Vet Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2021.07.043_b0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00430-007-0037-2","article-title":"Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparations","volume":"196","author":"Rabenau","year":"2007","journal-title":"Med Microbiol Immunol"},{"issue":"21","key":"10.1016\/j.vaccine.2021.07.043_b0240","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/j.vaccine.2014.02.088","article-title":"Interaction of porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccines on dually infected pigs","volume":"32","author":"Seo","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.07.043_b0245","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1746-6148-2-6","article-title":"Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease","volume":"2","author":"Meerts","year":"2006","journal-title":"BMC Vet Res"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.043_b0250","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.vaccine.2015.11.034","article-title":"Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera PCV MH) under experimental conditions","volume":"34","author":"Park","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.07.043_b0255","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.vetmic.2019.03.002","article-title":"Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge","volume":"231","author":"Park","year":"2019","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2021.07.043_b0260","article-title":"Targeted alteration of antibody-based immunodominance enhances the heterosubtypic immunity of an experimental PCV2 vaccine","volume":"8","author":"Rakibuzzaman","year":"2020","journal-title":"Vaccines-Basel"},{"issue":"27","key":"10.1016\/j.vaccine.2021.07.043_b0265","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1016\/j.vaccine.2012.04.022","article-title":"Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition","volume":"30","author":"Trible","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.07.043_b0270","first-page":"223","article-title":"Dynamics and persistence of Mycoplasma hyopneumoniae infection in pigs","volume":"69","author":"Fano","year":"2005","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.vaccine.2021.07.043_b0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175034","article-title":"Potential use of local and systemic humoral immune response parameters to forecast Mycoplasma hyopneumoniae associated lung lesions","volume":"12","author":"Garcia-Morante","year":"2017","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2021.07.043_b0280","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.vetmic.2007.09.008","article-title":"Control of Mycoplasma hyopneumoniae infections in pigs","volume":"126","author":"Maes","year":"2008","journal-title":"Vet Microbiol"},{"issue":"17","key":"10.1016\/j.vaccine.2021.07.043_b0285","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1016\/j.vaccine.2011.02.034","article-title":"Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2","volume":"29","author":"Kim","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2021.07.043_b0290","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2021.07.043_b0295","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fmicb.2014.00477","article-title":"Targeting regulatory T cells to improve vaccine immunogenicity in early life","volume":"5","author":"Ndure","year":"2014","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.043_b0300","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1017\/S1466252311000120","article-title":"Polymicrobial respiratory disease in pigs","volume":"12","author":"Opriessnig","year":"2011","journal-title":"Anim Health Res Rev"},{"key":"10.1016\/j.vaccine.2021.07.043_b0305","article-title":"Biological modulation of the treg: teff ratio: from immunosuppression to immunoactivation [Online First]","author":"Yang","year":"2020","journal-title":"IntechOpen"},{"key":"10.1016\/j.vaccine.2021.07.043_b0310","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/cei.12829","article-title":"The life cycle of a T cell after vaccination - where does immune ageing strike?","volume":"187","author":"Kim","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2021.07.043_b0315","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/925135","article-title":"CD4(+)T cells: differentiation and functions","author":"Luckheeram","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.vaccine.2021.07.043_b0320","first-page":"1","article-title":"The Imbalance between Foxp3+ Tregs and Th1\/Th17\/Th22 cells in patients with newly diagnosed autoimmune hepatitis","volume":"2018","author":"Liang","year":"2018","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.043_b0325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00428-019-02568-y","article-title":"The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status","volume":"475","author":"Glajcar","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.vaccine.2021.07.043_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155648","article-title":"Regulatory CD4+CD25+ T cells dampen inflammatory disease in murine mycoplasma pneumonia and promote IL-17 and IFN-gamma responses","volume":"11","author":"Odeh","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.07.043_b0335","doi-asserted-by":"crossref","first-page":"d930","DOI":"10.2741\/1098","article-title":"T lymphocyte responses are critical determinants in the pathogenesis and resistance to mycoplasma respiratory disease","volume":"8","author":"Jones","year":"2003","journal-title":"Front Biosci"},{"issue":"30","key":"10.1016\/j.vaccine.2021.07.043_b0340","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1016\/j.vaccine.2009.04.028","article-title":"One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model","volume":"27","author":"Fort","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2100921X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2100921X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:02:38Z","timestamp":1759402958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2100921X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":68,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0264410X2100921X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective immunity induced by concurrent intradermal injection of porcine circovirus type 2 and Mycoplasma hyopneumoniae inactivated vaccines in pigs","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}